Christopher Benecchi

Insider Reports History

Entity
Individual
Location
C/O Sage Therapeutics, Inc., 215 First Street, Cambridge, MA
Signature
Brandon Marsh, attorney in fact for Christopher Benecchi
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Benecchi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sage Therapeutics, Inc. Chief Operating Officer Common Stock 48.4K $335K $6.91 Apr 10, 2025 Direct
Sage Therapeutics, Inc. Chief Operating Officer Stock Options (Right to buy) 40K Jan 16, 2025 Direct
Sage Therapeutics, Inc. Chief Operating Officer Stock Option (Right to buy) 12.5K Nov 1, 2024 Direct

Insider Reports Filed by Christopher Benecchi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SAGE Sage Therapeutics, Inc. Apr 10, 2025 4 -$10K 4 Apr 11, 2025 Chief Operating Officer
SAGE Sage Therapeutics, Inc. Feb 13, 2025 1 -$5.9K 4 Feb 14, 2025 Chief Operating Officer
SAGE Sage Therapeutics, Inc. Jan 16, 2025 2 $0 4 Jan 21, 2025 Chief Operating Officer
SAGE Sage Therapeutics, Inc. Nov 1, 2024 2 $0 4 Nov 14, 2024 Chief Operating Officer
SAGE Sage Therapeutics, Inc. Aug 5, 2024 2 -$42.6K 4 Aug 7, 2024 Chief Business Officer
SAGE Sage Therapeutics, Inc. Feb 13, 2024 2 $0 4 Feb 15, 2024 Chief Business Officer
SAGE Sage Therapeutics, Inc. Feb 13, 2023 1 $0 4 Feb 15, 2023 Chief Business Officer
SAGE Sage Therapeutics, Inc. Feb 3, 2023 2 -$93.6K 4 Feb 7, 2023 Chief Business Officer
SAGE Sage Therapeutics, Inc. Jun 16, 2022 1 $0 4 Jun 21, 2022 Chief Commercial Officer
SAGE Sage Therapeutics, Inc. Feb 11, 2022 1 $0 4 Feb 15, 2022 Chief Commercial Officer
SAGE Sage Therapeutics, Inc. Oct 1, 2021 1 $0 4 Oct 4, 2021 Chief Commercial Officer
SAGE Sage Therapeutics, Inc. Sep 13, 2021 0 $0 3 Sep 13, 2021 Chief Commercial Officer